Edition:
India

BiondVax Pharmaceuticals Ltd (BVXV.OQ)

BVXV.OQ on NASDAQ Stock Exchange Capital Market

42.47USD
18 Sep 2020
Change (% chg)

-- (--)
Prev Close
$42.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
36,034
52-wk High
$61.50
52-wk Low
$5.26

Select another date:

Wed, Jul 1 2020

BRIEF-BiondVax Pharmaceuticals Reports Qtrly Loss Per Share Nis 0.01

* BIONDVAX PHARMACEUTICALS - AS OF MARCH 31, HAD CASH AND CASH EQUIVALENTS OF NIS 42.5 MILLION VERSUS NIS 72.4 MILLION AS OF DECEMBER 31

BRIEF-BiondVax's M-001 Universal Influenza Vaccine Candidate Achieves Primary Endpoints In Phase 2 Trial

* NIH REPORT ON PHASE 2 CLINICAL TRIAL OF BIONDVAX'S M-001 UNIVERSAL INFLUENZA VACCINE CANDIDATE CONCLUDES BOTH PRIMARY ENDPOINTS ACHIEVED

Select another date: